Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study

Background Caffeine citrate (CC)-induced excessive energy expenditure, diuresis, natriuresis, and other CC-associated potential side effects (CC-APSEs) result in lower daily weight gain (WG) in premature neonates. This study aimed to assess higher CC-doses’ effect on the mean daily-WG (MD-WG) and CC...

Full description

Bibliographic Details
Main Authors: Ijaz Hussain, Manoj Kumar, Amin Ali, Fizzah Naz, Wasif Ahmed Khan, Muhammad Sohail Salat, Shahzad Rauf, Gul Ambreen, Kashif Hussain
Format: Article
Language:English
Published: SAGE Publishing 2024-04-01
Series:Dose-Response
Online Access:https://doi.org/10.1177/15593258241247185
_version_ 1827284560452255744
author Ijaz Hussain
Manoj Kumar
Amin Ali
Fizzah Naz
Wasif Ahmed Khan
Muhammad Sohail Salat
Shahzad Rauf
Gul Ambreen
Kashif Hussain
author_facet Ijaz Hussain
Manoj Kumar
Amin Ali
Fizzah Naz
Wasif Ahmed Khan
Muhammad Sohail Salat
Shahzad Rauf
Gul Ambreen
Kashif Hussain
author_sort Ijaz Hussain
collection DOAJ
description Background Caffeine citrate (CC)-induced excessive energy expenditure, diuresis, natriuresis, and other CC-associated potential side effects (CC-APSEs) result in lower daily weight gain (WG) in premature neonates. This study aimed to assess higher CC-doses’ effect on the mean daily-WG (MD-WG) and CC-APSE development, considering 5 mg/kg/day as the standard regimen. Method This retrospective cohort study included neonates of ≤36 weeks gestational age and received CC-therapy. The same participants were followed for data analysis in two postnatal phases: 15–28 and 29–42 days of life (DOL). Based on daily CC-dose, formed group-I=(5 mg/kg/day), group-II=(>5–7 mg/kg/day), and group-III=(>7 mg/kg/day). Data was analyzed separately for group-II and group-III using group-I as the standard. Results The study included 284 neonates. During phase-I, the MD-WG was significantly higher in group-I than group-II (19.9 ± .88 g/kg/d vs 17.5 ± .49, P = .031) and group-III (19.9 ± .88 g/kg/d vs 16.7 ± .71, P < .001). During 29–42 DOL, the MD-WG of group-I was only significantly higher than group-III (21.5 ± .42 g/kg/d vs 18.1 ± .39 g/kg/d, P = .003) and comparable with group-II. During 15–28 DOL, CC-APSEs were significantly higher in group-II and group-III but during 29–42 DOL was significant only in group-III. Conclusion Exposure to higher caffeine doses in this study cohort is associated with lower postnatal WG in preterm neonates than standard daily doses may be due to its catabolic effects and CC-APSEs.
first_indexed 2024-04-24T09:58:25Z
format Article
id doaj.art-27180460c89d47f78269fa0aa01b8d62
institution Directory Open Access Journal
issn 1559-3258
language English
last_indexed 2024-04-24T09:58:25Z
publishDate 2024-04-01
publisher SAGE Publishing
record_format Article
series Dose-Response
spelling doaj.art-27180460c89d47f78269fa0aa01b8d622024-04-14T02:04:39ZengSAGE PublishingDose-Response1559-32582024-04-012210.1177/15593258241247185Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort StudyIjaz HussainManoj KumarAmin AliFizzah NazWasif Ahmed KhanMuhammad Sohail SalatShahzad RaufGul AmbreenKashif HussainBackground Caffeine citrate (CC)-induced excessive energy expenditure, diuresis, natriuresis, and other CC-associated potential side effects (CC-APSEs) result in lower daily weight gain (WG) in premature neonates. This study aimed to assess higher CC-doses’ effect on the mean daily-WG (MD-WG) and CC-APSE development, considering 5 mg/kg/day as the standard regimen. Method This retrospective cohort study included neonates of ≤36 weeks gestational age and received CC-therapy. The same participants were followed for data analysis in two postnatal phases: 15–28 and 29–42 days of life (DOL). Based on daily CC-dose, formed group-I=(5 mg/kg/day), group-II=(>5–7 mg/kg/day), and group-III=(>7 mg/kg/day). Data was analyzed separately for group-II and group-III using group-I as the standard. Results The study included 284 neonates. During phase-I, the MD-WG was significantly higher in group-I than group-II (19.9 ± .88 g/kg/d vs 17.5 ± .49, P = .031) and group-III (19.9 ± .88 g/kg/d vs 16.7 ± .71, P < .001). During 29–42 DOL, the MD-WG of group-I was only significantly higher than group-III (21.5 ± .42 g/kg/d vs 18.1 ± .39 g/kg/d, P = .003) and comparable with group-II. During 15–28 DOL, CC-APSEs were significantly higher in group-II and group-III but during 29–42 DOL was significant only in group-III. Conclusion Exposure to higher caffeine doses in this study cohort is associated with lower postnatal WG in preterm neonates than standard daily doses may be due to its catabolic effects and CC-APSEs.https://doi.org/10.1177/15593258241247185
spellingShingle Ijaz Hussain
Manoj Kumar
Amin Ali
Fizzah Naz
Wasif Ahmed Khan
Muhammad Sohail Salat
Shahzad Rauf
Gul Ambreen
Kashif Hussain
Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study
Dose-Response
title Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study
title_full Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study
title_fullStr Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study
title_full_unstemmed Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study
title_short Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study
title_sort dose response study of caffeine on postnatal weight gain in premature neonates a retrospective cohort study
url https://doi.org/10.1177/15593258241247185
work_keys_str_mv AT ijazhussain doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy
AT manojkumar doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy
AT aminali doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy
AT fizzahnaz doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy
AT wasifahmedkhan doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy
AT muhammadsohailsalat doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy
AT shahzadrauf doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy
AT gulambreen doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy
AT kashifhussain doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy